QA/QC & Analytical Techniques In-Depth Focus 2020
Posted: 18 February 2020 | European Pharmaceutical Review | No comments yet
Within this in-depth focus are articles on how the regulation of heavy metals in cannabis can benefit from lessons learned in pharma and the advantages of using electron paramagnetic resonance (EPR) as an imaging technique.
- The ever-increasing demand for cannabis-based products requires US state regulators to set guidelines that ensure products are safe for human use. However, as medicinal cannabis moves forward at a rapidly increasing pace, regulations are falling behind. Here, Robert Thomas discusses the many inconsistencies across US states for monitoring levels of elemental contaminants in cannabis-based products and suggests that the pharmaceutical community could offer some much-needed guidance on how best to prepare the cannabis industry for federal oversight.
- Analogous to nuclear magnetic resonance spectroscopy, EPR measures electron spins, rather than those of atomic nuclei. Its investigative power has always offered unique insight, but it seems that only now is the technique coming into its own.
